Regulatory FDA moves toward easing restrictions on certain peptides BioPharma DiveThe agency s decision to hold an advisory committee meeting on the topic comes after HHS Secretary Robert F.RegulatoryRead full story pharminent April 16, 2026 (Last updated: April 17, 2026) BioPharma Dive The agency s decision to hold an advisory committee meeting on the topic comes after HHS Secretary Robert F. RegulatoryRead full story Post navigation Previous: Lilly’s new obesity pill passes heart safety test in diabetesNext: Erica Schwartz, ex-deputy surgeon general, picked to be next CDC director Related Stories Regulatory Ultragenyx wins FDA approval for first treatment targeting root cause of GSDIa pharminent August 20, 2026 Regulatory Regeneron wins FDA approval to challenge Ipsen for rare bone disease market pharminent August 20, 2026 Regulatory FDA grants accelerated approval to Ultragenyx’s Genglycos gene therapy pharminent August 20, 2026
